1379 PDF PDF
1379 PDF PDF
1379 PDF PDF
REVIEW ARTICLE
namely; saliva and gingival crevicular fluid (GCF), immunosorbent assays, trypsin-like protease
indicative of health or disease. assays, DNA probes 9 and the PCR 10.
These tests are technique sensitive making Among these tests, chairside periodontal kits
harvesting of a sample and reproducing the results provide immediate reports of the microflora
a tedious task. Also, the specificity and sensitivity associated with the disease compared to
of these diagnostics is fundamentally limited by cumbersome and time-consuming traditional
their inability to simultaneously measure the local laboratory procedures. Chairside periodontal test
concentration of multiple biomarkers. Hence rapid kits can be categorized as
chair side diagnostic tests should be developed that 1. Microbiological test kits
provide maximum information with minimal 2. Biochemical test kits
technicalities. 3. Genetic kits.
More than 200 species of microorganisms colonize
the oral cavity, but only a few of these are thought 1. Microbiological test kits
to be pathogens. 3 Among the subgingival bacterial Enumeration and identification of the microflora of
species identified so far, Porphyromonas gingivalis the periodontal pocket have been an important part
(Pg), Prevotella intermedia (Pi) and of research efforts for many decades. It is thought
Aggregatibacter actinomycetemcomitans (Aa) have that as many as 300 distinct bacterial species can
been associated with progressive periodontitis4. Aa inhibit the periodontal pocket. Many of these have
is infrequently found in periodontally healthy not been identified.
individuals 5, whereas Pi has been found in either The microbiological tests have the potential to
healthy subjects or patients with gingivitis 6. support the diagnosis of various forms of
Elevated levels of these putative pathogens may be periodontal disease, to serve as indicators of
useful indicators of both active periodontitis and disease initiation and progression and to determine
increased risk of gingival attachment loss. which periodontal sites are at higher risk for active
The goal of periodontal diagnostic procedures is to destruction. The bacteriological tests (Microscopy,
provide useful information to the clinician Culture, Omnigene, Affirm DP and Evalusite) are
regarding the present periodontal disease type, mainly aimed at spirochetes, Aa, Pg and Pi.
location and severity. Traditional clinical Microbial tests can also be used to monitor
measurements (probing pocket depth, bleeding on periodontal therapy directed towards the
probing, clinical attachment loss, plaque index, suppression or eradication of periodontopathogenic
radiographs) used for periodontal diagnosis are organisms.
often of limited usefulness in that they are
indicators of previous periodontal disease rather
Omnigene
than present disease activity.
These are DNA probe systems for a number of
The ideal diagnostic test should be 7, 8:
known periodontopathogen subgingival bacteria.
1. Highly specific, sensitive, reproducible and
OmniGene Diagnostics, Inc. has applied the
quantitative.
principles of genetic engineering to develop
2. Simple to perform, rapid, one-stage or a two-
species-specific DNA probe tests for eight
stage procedure.
periodontal pathogens (Porphyromonas gingivalis,
3. Non-invasive.
Prevotella intermedia, Actinobacillus
4. Versatile in terms of sample handling, storage
actinomycetem-comitans, Fusobacterium
and transport.
nucleatum, Eikenella corrodens, Campylobacter
5. Amenable to chairside use.
rectus, Bacteroides forsythus, and Treponema
6. Economical.
denticola). The test requires minimal effort on the
part of the clinician: subgingival plaque samples
Objectives of chair side tests
are collected from the patient and sent through the
1. They are minimally invasive, thus having an
mail for analysis by OmniGene Diagnostics' fully
edge over conventional diagnostic aids.
licensed clinical reference laboratory. Results are
2. Relatively less tedious to the patient as the
transmitted to the practitioner by phone, fax, or
appointment time is reduced.
mail. The use of diagnostic tests for periodontal
3. Less cumbersome or technique sensitive, making
pathogens is a relatively new concept in dentistry
them user friendly.
and acceptance of the OmniGene Diagnostics tests
4. Help in early diagnosis and treatment planning.
by the dental marketplace has been slower than
5. Can be used as an encouragement tool to
anticipated. OmniGene Diagnostics' challenge for
motivate the patient.
the future is to persuade the dental community that
monitoring periodontal pathogen levels, as well as
Several methods have been employed to detect
other clinical indicators of disease, is essential to
putative periodontopathogens in clinical samples.
providing optimal care to the periodontitis patient.11
These include cultural methods, microscopy,
immunofluorescent assays, enzyme-linked
Merits
1. Reports are provided within short periods of PerioScan®
time, few hours to few days. Perioscan is a diagnostic test kit that utilizes the
2. It helps in identification of number of known BANA (N-benzoyl-DLarginine- 2 naphthylamide)-
periodontal pathogen12 hydrolysis reaction, developed to detect bacterial
trypsin-like proteases in the dental plaque. The
microbial-enzymatic BANA test is one of the
modern alternatives to bacterial cultures. It detects
the presence of three periodontal pathogens in the
subgingival plaque (T. denticola, P. gingivalis, and
B. forsythus).
The BANA test (Figure 3) was developed by Dr.
Walter Löesche and co-workers at Michigan
University, being the result of more than 15 years
of research. Of the 60 bacterial species studied in
the subgingival microbiota, only the anaerobic
bacteria Porphyromonas gingivalis, Bacteroides
forsythus and Treponema denticola possess a
Figure 1- Omnigene trypsin-like enzyme, which hydrolyzes the
synthetic peptide benzoyl- DL-arginine-
Evalusite (Kodak) naphthylamide or BANA. The test can detect the
It is a novel membrane immunoassay commercially presence of these three anaerobic species, without
available in Europe and Canada for the Chairside being able to differentiate them15.
detection of 3 periodontal pathogens. It involves The BANA test is very sensitive, detecting small
linkage between the antigen and a membrane quantities of pathogens. No meaningful differences
bound antibody to form an immunocomplex that is could be found between DNA probes,
revealed through a calorimetric reaction. The immunological reagents and the BANA test, when
patient plaque sample is prepared by the addition of seeking to detect these species in plaque samples
a detergent, mixed and then squeezed through a removed from periodontal disease patients.16,17,18
filter into a reagent well. Membrane bound The test can be used for assessment of oral
antibody in the well specific to halitosis, to detect the presence of two BANA
A.actinomycetemcomitans, P.gingivalis and positive species on the tongue surface:
P.intermedia reacts with plaque sample. Antigen Stomatococcus mucinlagenous and Rothia
and antibody complexes formed on the membrane dentocariosa.
are detected by the addition of an enzyme-labelled
second antibody together with a colored enzyme
substrate. Separate dots indicate the presence of 3
different species.13
Merits
It employes a normal membrane base enzyme
immunoesaay for the detection of three putative
periodonto pathogens. (Aa, Pg, Pi).
Demerits
1. It is multistage test.
2. It has a subjective calorimetric end point.
3. There is no permanent record of the result.
4. Gives the assumption that the three organisms Figure 3 - BANA Test
are causing the disease. 14
Principle of BANA test
Peptidases of these three bacterial species (T.
denticola, P. gingivalis, and B. forsythus) can
hydrolyze the peptide analog N-benzoyl-DL-
arginine-2 naphthylamide (BANA). One of the
hydrolytic products of this reaction is B-
naphthylamide, which reacts with a reagent, which
is imbedded in the upper strip of the test, producing
a permanent blue color. Blood and saliva do not
19
interfere with the test .
Figure 2 - Evalusite
elastase in GCF may thus be indicative of active catalyzed to oxaloacetate and glutamate. The
disease sites 24. Although a relationship between addition of a dye such as fast red results in a color
elastase levels in GCF and periodontal disease product, the intensity of which is proportional to
activity has been reported, the position is still far the AST activity in the GCF sample. In practice,
from clear. Further clinical trials are needed before the PerioGard assay suffers from poor
the value of this test kit in clinical practice can be differentiation between colors and is a relatively
ascertained. complex procedure involving multiple steps.
Periocheck PerioWatch
Periocheck (Advanced Clinical Technologies Inc., The PerioWatch was developed as a simple method
Westwood, MA 02090, USA) is a rapid chairside of analyzing Asparate amino Transferase (AST) at
test to detect the presence of neutral proteases. the chairside. The principle of this test is that, in the
Periocheck has FDA (Food and Drug presence of pyridoxal phosphate, AST catalyzes the
Administration) approval in the United States. The transfer of an amino group from cysteinesulfinic
presence of these enzymes has been implicated in acid, by a aketoglutaric acid to yield β-sulfinyl
collagen breakdown which is an important feature pyruvate and glutamate. β-sulfinyl pyruvate rapidly
of periodontal disease. Crevicular fluid is collected decomposes and releases inorganic sulfite which
on filter paper strips and these are placed on a react with malachite green to convert from a green
collagen dye labelled gel matrix. Soluble dye- dye to colourless form. The rate of conversion of
labelled fragments of collagen are formed from the malachite green is directly proportional to the AST
reaction of neutral proteases with the gel and these concentration.
diffuse onto the sample strip turning the papers
colour to blue. The quantity and intensity of the
colour reaction is compared to a standard colour
3. Genetic test kits
Various gene polymorphisms are considered to be
chart and is related to the level of neutral protease
risk factors for the initiation or progression of
activity originally present in the crevicular fluid
periodontal disease. In 1997, Kornman et al. 29
sample.25 The test is only qualitative and not
found an association between the polymorphism in
specific for PMNL collagenase, which is thought to
the genes encoding for interleukin-1α and
be the dominant collagenase at active sites 26.
interleukin-1β and increased severity of
Indeed, a high proportion of the enzyme is likely to
periodontitis. Identification of the genetic
be bacterial in origin. Furthermore, interproximal
polymorphism is difficult but now some chairside
sites cannot be sampled, due to the risk of saliva
kits are available for its detection.
contamination, and this is clearly a major drawback
with this method. It is the most rapid chairside test
for neutral proteases in GCF like elastases, PST Genetic Susceptibility Test
proteinases and collagenases. The levels of these Ever wonder why some people with loads of plaque
enzymes in GCF have been noted to increase with don't get attachment loss and others with good
the development of gingivitis as well as sites of hygiene are losing teeth? Common sense and more
established periodontitis. recently science indicate that there is an inherited
component of periodontal disease that is very
important in determining disease behaviour.
PerioGard
Clinicians have recognized for years that some
PerioGard is based on the detection of an enzyme
individuals get lots of plaque and calculus, but
called aspartate aminotransferase (AST). AST is a
experience little loss of periodontal support. Other
soluble intracellular cytoplasmic enzyme that is
patients seem to have really clean mouths, but
released from within the cell upon its death. Since
experience extensive bone loss. Their disease is not
cell death is an important part of periodontal
so much related to the presence of bacteria but to
pathogenesis, AST levels in GCF have great
some other factor. Within the past two years, a
potential as markers of early periodontal tissue
genetic marker has been identified that can be
destruction. Elevated total AST levels in a 30-
correlated with the degree of tissue destruction that
second sample have been positively associated with
occurs in some periodontal patients with advanced
disease-active sites in contrast to inactive sites 27,28.
disease. Conventional forms of therapy such as
This commercial test consists of a tray with two
cleaning the gingival pockets etc. often, experience
test wells for each tooth, and appropriate reagent
has shown, fail to be effective. An American
for conducting the test. The test involves collection
research team was able to show for the first time
of GCF with the filter paper strip which is then
that these patients to a disproportion extent (> 50
placed in tromethamine hydrochloride buffer. A
%) had a genetic defect in a certain component of
substrate reaction mixture containing 1-aspartic and
the immune system. This leads to over-production
α-keto-gluteric acid is added to the sample and
of an important local inflammatory mediator in the
allowed to react for ten minutes. In the presence of
immune system, namely interleukin-1 (IL-1). The
AST, the Aspartate and α keto-gluteric acid are
16. Lõesche WJ. Comparison of the benzoyl- crevicular fluid. J Periodont Res 1993;28:266-273.
DLarginine- naphthylamide (BANA) test, DNA 27. Persson G, De Rouen T, Page R. Relationship
probes, and immunological reagents for ability to between levels of aspartate aminotransferase in
detect anaerobicicic periodontal infections due to gingival crevicular fluid and active tissue
Porphyromonas gingivalis, Treponema denticola destruction in treated chronic periodontitis patients.
and Bacteroides forsythus. J. Clin Microbiol. 1992; J Periodont Res 1990;25:81-87.
30: 427-433. 28. Chambers D, Imrey P, Cohen R, Crawford J,
17. Lõesche WJ, Giordano J, Soehren S, Alves M, Mcswiggin T. A longitudinal study of
Hutchinson R, Rau CF, Walsh L, et al. The non- aspartate aminotransferase in human gingival
surgical treatment of periodontal patients. Oral crevicular fluid. J Periodont Res 1991;26: 65-74.
Med Oral Surg Oral Path. 1996; 81: 533-543. 29. Kornman K, Crane A. The interleukin-1
18. Lõesche WJ, Taylor GW, Giordano J, genotype as a severity factor in adult periodontal
Hutchinson R, Rau CF, Chen Y-M, et al. A logistic disease. J Clin Periodontal 1997;24;72-77.
regression model for the decision to perform access
surgery. J. Clin Periodontol. 1997; 24: 171-179.
19. Bretz W, Loesche W. Characteristics of
Trypsin- Like Activity in Subgingival Plaque
Samples,.J. Dent. Res. 1987; 66: 1668-1672.
20. Essential of periodontology, Sahitya Reddy S,
microbiological diagnostic aids in periodontology,
chapter-46, page 467-474.
21. Laughton B, Syned S, Loesche W. API ZYM
system for identification of Bacteroides ssp.,
Capnocytophagia ssp., and spirochaetes of oral
origin. J Clin Microbial 1982;15:97-127.
22. Loesche W, Syed S, Stoll J. Trypsin-like
activity in sub-gingival plaque: A diagnostic
marker for spirochetes and periodontal disease? J
Periodont 1987;58:266-273.
23. http://www.e-dental.com/doc/periodontal-
probe-0001.
24. Armitage G, Jeffcoat M, Chadwick D et al.
Longitudinal evaluation of elastase as a marker for
the progression of periodontitis. J Periodontol
1994;65; 120.
25. Hemming K.W, Griffiths G.S. and Bulman J. S.
Detection of neutral protease (Periocheck) and
BANA hydrolase (Perioscan) compared with
traditional clinical methods of
diagnosis and monitoring of chronic inflammatory
periodontal disease. J Clin Periodontol 1997: 24:
110-114.
26. Chapple I, Matthews J, Thorpe G, Glenwright
H, Smith J, Saxby M. A new ultrasensitive
chemiluminescent assay for the sitespecific
quantification of alkaline phosphatase in gingival